Party Who Does Not Face Infringement Risk Lacks Standing to Appeal Adverse PTAB Decision: Federal Circuit | Practical Law
In Phigenix, Inc. v. Immunogen, Inc., the US Court of Appeals for the Federal Circuit held that Phigenix, Inc. lacked standing to appeal an adverse Patent Trial and Appeal Board (PTAB) decision because Phigenix did not face a risk of infringing the challenged patent.